R3S meet at Sheraton Grand PUNE.
Dr Vaishali Deshmukh Diabetologist
Dr Suhas Erande Diabetologist
Dr Rahul Patil Cardiologist
On Rising Diabetes and Heart Disease: new trend in management
Audience: All Physicians of PUNE
Setting new paradigms
Dr. Rahul Patil conducts angioplasty through a complex radial approach…
Sixty-five-year-old Jawarilal Mutha came to Hridayam Heart Care Clinic with complaints of breathlessness and chest pain. Weighing 130 kg he had high blood pressure and the heart rate was fast and irregular. As a consequence, several doctors refused to operate upon him. Dr. Rahul Patil performed a successful angioplasty on Mutha through a radical approach at the Ruby Hall Clinic, with Dr. C N Makhale and cardiac anesthetists assisting him. In India, only two to three percent of angioplasty surgeries have been performed through the radial approach.
It is predicted by experts in the field that this radial approach of angioplasty will be used widely in the near future. After a routine check-up at Nasik, angiography from the right thigh/groin of Jawarilal Mutha was conducted. This angiography did not do much good to him and soon, there was a need for angioplasty. Considering his overweight and critical blockages in his main vessels, performing angioplasty was very risky. Dr. Patil, who advised Mutha to go for angioplasty through the radial approach. The angioplasty was then successfully performed on him with a medicated long stent. The process lasted only for 30 minutes and Mutha came out walking happily.
The radial approach of angioplasty has a number of advantages over the femoral one. Not only the blood loss is minimal, but time for actual surgery and recovery is comparative Quite low. Also, another important factor is that the cost is equivalent to the other method of angioplasty. The radial approach is not just beneficial to obese patients but to all in need of angioplasty. As performing this type of angioplasty is relatively difficult and thus most of the doctors prefer the femoral approach over the radial one. A consultant interventional cardiologist with a fellowship in Interventional Cardiology from the Netherlands, Dr. Rahul Patil has recently received the ‘Best Challenging Case Award at Washington and has been practicing at Ruby Hall Clinic and the Noble Hospital since 2006.
Dr. Rahul Raosaheb Patil is an accomplished Interventional Cardiologist in Pune, practicing since 2006. He is Director, Interventional Cardiology, at Hridayam Heart Care Clinic in Pune, and has also served as a Consultant Cardiologist at Ruby Hall Clinic since 2006. In addition, Dr. Patil teaches at BJ Medical College & Sassoon General Hospital, in the capacity of Assistant Professor.
As an Interventional Cardiologist, Dr. Rahul Patil’s main clinical focus areas are Complex Coronary Angiography, Chronic Total Occlusions, Percutaneous Aortic Valve Replacement, Cardiovascular Disease, Mitral Valvuloplasty and Coronary Artery Disease.
CONFLUENCE SUMMIT by Sanofi arranged at PCMC
TOPIC: Diabetic Hypertension: Evidence-based approach
Speaker: Dr. RAHUL Patil
Cardiologist
Dr. Vaishali Deshmukh
Endocrinologist
Dr. RAVINDRA Sethia
Senior physician
The meeting was focused on reducing cardiac events like heart attack’s by giving PCSK9 agent in high-risk statin resistant / intolerant patients
Attended by 15 cardiologists across India.
This is the future in the management of heart patients.
ESC GUIDELINES OF HYPERTENSION
SPEAKERS :
Cardiologist : Dr Sachin Lakade
Dr Abhay somany
Dr Rajesh Wagh
Endocrinologist: Dr Harshal Ekatpure
Session moderated by Dr. Rahul Patil, Senior consultant Cardiologist, Ruby Hall Clinic , Pune.
Day 1 Awake Aortic valve replacement under local anesthesia
Day 1: After 9 Hours of Valve replacement
Day 3: Discharge without a single stitch on body
Transcatheter aortic valve implantation (TAVI) or transcatheter aortic valve replacement (TAVR), is the replacement of the aortic valve of the heart through the blood vessel without open-heart surgery. The replacement valve is delivered by a transfemoral approach ie groin like Angioplasty.
Severe symptomatic aortic stenosis carries a poor prognosis with a life expectancy of 2 to 5 years after diagnosis. Until recently, surgical aortic valve replacement was the standard of care in adults with severe symptomatic aortic stenosis. However, the risks associated with surgical aortic valve replacement are increased in elderly patients and those with concomitant severe systolic heart failure or coronary artery disease, as well as in people with comorbidities such as cerebrovascular and peripheral arterial disease, chronic kidney disease, and chronic respiratory dysfunction.
The first implantation in a patient was performed in 2002 on April 16 by Alain Cribier in Hospital Charles Nicolle, at the University of Rouen
This therapy got USFDA approval in 2011, two major companies which manufacture Valve is Edwards’ Sapien aortic valve is made from bovine pericardial tissue and is implanted via a catheter-based delivery system and Medtronic’s CoreValve Transcatheter Aortic Valve is constructed of a self-expanding Nitinol frame and delivered through the femoral artery. This device received FDA approval in January 2014.
Indian manufactured MyValve is CE approved and Indian DCGI approved from Meril Lifesciences, it started with the Pilot study in India 2017, following which it got DCGI approval, It is available for commercial use since 2018. To date, this 400 numbers of valves are deployed in India and abroad. My valve has received great recognition in Europe and the middle east due to its smooth deliverability and lesser adverse events.
Ruby Hall clinic has delivered such 3 TAVR valves till now, but Young cardiologist Dr. Rahul Patil, Interventional cardiologist, Ruby hall clinic, Pune did this procedure as primary operator along with Proctor Dr. Anmol Sonawane and associate Dr. C N Makhale, Dr. Bikas Sahoo cardiac anesthetist on 13/10/2019 Sunday at 10 am in a 65-year-old Mr. Bashir shaikh from Pune. This procedure was done under local anesthesia in the awake state of the patient during procedure like routine angioplasty. The procedure time was 1 hour only. Dr. P K Grant congratulated the team of Dr. Rahul Patil for his excellent work.
The patient was mobilized after 9 hours, shifted from CCU after 24 hours and discharged on 3 rd day of procedure.
As a conventional Surgical aortic valve replacement, the patient has to undergo open-heart surgery on heart-lung machine where operation time is 4 hours, it involved 10 to 12 % of Morbidity and mortality. Patient has to kept on Ventilator for 24 hours, Patient remains in surgical ICU for 4 days, and total hospitalization for 10 days. It takes 3 weeks for complete healing of stitches over the chest wall, and 2 to 3 months for sternal fracture healing. This procedure also involves the risk of embolic brain stroke in 5 to 6 %of patients.
Today, TAVI is recommended not only in high surgical risk patients but also in moderate to low-risk patients.
Dr. Rahul Patil has been trained in the Netherlands for TAVI in 2009 and now he owes promise to all his high-risk heart valve disease patients who can be treated without undergoing open-heart surgery.
For more information watch this video:
Dear friends,
Its was the great meeting for CSI with attendance of 50+ cardiologist, I would like to thank each and everyone who participated.
Dr. Shirish Sathe was the opening batsman of session of Heart transplant symposium,
he did a great job on insight on LVAD; IABP. VS IMPALA.
SHOCK I AND II TRIAL
Learning lesson was,
Identify high-risk patients? of cardiogenic shock and deploy early; more benefit as per trial base evidence.
Dr. Bikas Sahoo spoke on ECMO IN HEART DISEASE patients was quite promising.
Dr. JS Hiremath Sir rocked the meeting by presenting pre and post-management of heart transplant patients!!!!
It was a true learning !!!!
Impella device hands-on experience counter stole the
Show.
Ruby hall transplant program and statistics were the crux, of outcome of heart transplant patients!!!
In a short period of time Ruby hall clinic, Heart transplant program has given results more than international standards !!!
I sincerely thank EMCURE AND TRANSLUMINA THERAPEUTIC to support this meeting
I promise you all that future meetings will also help you in your day to day clinical practice
All the meetings are done with great help and coordination of Dr. Rajeev Sethi, President CSI..!